Karyopharm Therapeutics Inc Cash Flow-to-Debt Ratio
Karyopharm Therapeutics Inc cash flow-to-debt ratio. Karyopharm Therapeutics Inc (KPTI) has a Cash Flow-to-Debt Ratio of -0.06x as of June 2026, meaning its operating cash flow of $-24.93 Million could theoretically repay 0% of its total liabilities ($441.49 Million) in one year. Check KPTI cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Karyopharm Therapeutics Inc (2011–2025)
Cash flow-to-debt ratio of Karyopharm Therapeutics Inc from 2011 to 2025. Historical debt coverage capacity for Karyopharm Therapeutics Inc across 15 annual periods. Check how aggressively does Karyopharm Therapeutics Inc reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Karyopharm Therapeutics Inc Cash Flow-to-Debt Ratio by Year (2011–2025)
Karyopharm Therapeutics Inc cash flow-to-debt ratio by year from 2011 to 2025. Year-by-year debt coverage analysis for Karyopharm Therapeutics Inc. For the full cash flow conversion analysis, see how efficiently does Karyopharm Therapeutics Inc generate cash.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.19x | $-75.37 Million | $401.34 Million | ▲ +48.4% |
| 2024 | -0.36x | $-127.49 Million | $350.44 Million | ▼ -47.8% |
| 2023 | -0.25x | $-92.72 Million | $376.64 Million | ▲ +38.3% |
| 2022 | -0.40x | $-149.55 Million | $374.83 Million | ▼ -43.4% |
| 2021 | -0.28x | $-107.12 Million | $384.98 Million | ▲ +54.4% |
| 2020 | -0.61x | $-160.23 Million | $262.50 Million | ▲ +21.6% |
| 2019 | -0.78x | $-190.82 Million | $245.19 Million | ▲ +22.7% |
| 2018 | -1.01x | $-159.12 Million | $158.02 Million | ▲ +30.6% |
| 2017 | -1.45x | $-73.72 Million | $50.83 Million | ▲ +68.8% |
| 2016 | -4.65x | $-84.39 Million | $18.14 Million | ▲ +15.5% |
| 2015 | -5.51x | $-94.03 Million | $17.08 Million | ▼ -44.9% |
| 2014 | -3.80x | $-51.45 Million | $13.54 Million | ▲ +58.7% |
| 2013 | -9.20x | $-30.29 Million | $3.29 Million | ▼ -1631.6% |
| 2012 | -0.53x | $-15.51 Million | $29.19 Million | ▼ -23.5% |
| 2011 | -0.43x | $-8.55 Million | $19.88 Million | — |